GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Purchase Of Investment

Biomics Biopharma (ASX:BBM) Purchase Of Investment : A$ Mil (TTM As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Purchase Of Investment?

Biomics Biopharma's purchase of investment for the six months ended in . 20 was A$0.00 Mil. It means Biomics Biopharma spent A$0.00 Mil on purchasing investments.

Compared with last quarter (A$0.00 Mil in . 20 ), Biomics Biopharma spent the same money on purchasing investments in . 20 (A$0.00 Mil).


Biomics Biopharma Purchase Of Investment Historical Data

The historical data trend for Biomics Biopharma's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Purchase Of Investment Chart

Biomics Biopharma Annual Data
Trend
Purchase Of Investment

Biomics Biopharma Semi-Annual Data
Purchase Of Investment

Biomics Biopharma Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.


Biomics Biopharma Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomics Biopharma (ASX:BBM) Business Description

Traded in Other Exchanges
N/A
Address
1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines